Canada Life’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.5M Sell
294,065
-2,116
-0.7% -$147K 0.03% 383
2025
Q4
$19.7M Sell
296,181
-69,645
-19% -$4.5M 0.03% 373
2025
Q3
$24.3M Sell
365,826
-7,069
-2% -$559K 0.03% 390
2025
Q2
$32.6M Buy
372,895
+35,294
+10% +$2.77M 0.05% 310
2025
Q1
$23.1M Buy
337,601
+67,841
+25% +$5.54M 0.04% 377
2024
Q4
$21M Sell
269,760
-100,376
-27% -$7.43M 0.04% 404
2024
Q3
$24.8M Buy
370,136
+10,673
+3% +$876K 0.04% 362
2024
Q2
$40.8M Buy
359,463
+61,050
+20% +$7.72M 0.08% 238
2024
Q1
$41.4M Buy
298,413
+9,662
+3% +$1.21M 0.08% 232
2023
Q4
$35.7M Buy
288,751
+747
+0.3% +$76.3K 0.08% 254
2023
Q3
$26.9M Sell
288,004
-6,710
-2% -$756K 0.06% 290
2023
Q2
$38.1M Buy
294,714
+22,150
+8% +$2.68M 0.09% 222
2023
Q1
$31.7M Buy
272,564
+2,576
+1% +$288K 0.08% 258
2022
Q4
$30.7M Sell
269,988
-3,405
-1% -$374K 0.08% 252
2022
Q3
$22M Sell
273,393
-1,261
-0.5% -$107K 0.06% 308
2022
Q2
$20.5M Sell
274,654
-2,142
-0.8% -$195K 0.05% 344
2022
Q1
$37.3M Sell
276,796
-1,156
-0.4% -$126K 0.08% 261
2021
Q4
$37.2M Sell
277,952
-40
-0% -$5.75K 0.08% 262
2021
Q3
$38.2M Sell
277,992
-7,996
-3% -$1.01M 0.09% 247
2021
Q2
$30.5M Sell
285,988
-1,784
-0.6% -$171K 0.07% 299
2021
Q1
$25.7M Buy
287,772
+4,980
+2% +$467K 0.06% 328
2020
Q4
$26.1M Buy
282,792
+32,996
+13% +$2.95M 0.05% 364
2020
Q3
$25.7M Buy
249,796
+5,508
+2% +$575K 0.06% 315
2020
Q2
$24.7M Buy
244,288
+46,616
+24% +$4.17M 0.06% 310
2020
Q1
$13.4M Sell
197,672
-8,476
-4% -$527K 0.04% 394
2019
Q4
$11.2M Sell
206,148
-18,060
-8% -$857K 0.02% 532
2019
Q3
$8.37M Buy
224,208
+4,124
+2% +$160K 0.02% 570
2019
Q2
$8.23M Buy
220,084
+33,664
+18% +$1.06M 0.02% 603
2019
Q1
$5.54M Buy
186,420
+89,200
+92% +$3.13M 0.01% 626
2018
Q4
$2.78M Buy
97,220
+56,900
+141% +$1.8M 0.01% 845
2018
Q3
$1.44M Buy
40,320
+1,120
+3% +$34.7K ﹤0.01% 1368
2018
Q2
$931K Sell
39,200
-3,712
-9% -$78.7K ﹤0.01% 1555
2018
Q1
$797K Hold
42,912
﹤0.01% 1594
2017
Q4
$614K Sell
42,912
-60,392
-58% -$785K ﹤0.01% 1674
2017
Q3
$1.17M Sell
103,304
-1,304
-1% -$23.1K ﹤0.01% 1464
2017
Q2
$1.91M Sell
104,608
-5,044
-5% -$93.2K 0.01% 1179
2017
Q1
$2.32M Buy
109,652
+6,588
+6% +$129K 0.01% 1029
2016
Q4
$1.54M Buy
103,064
+65,076
+171% +$1.15M ﹤0.01% 1255
2016
Q3
$831K Hold
37,988
﹤0.01% 1514
2016
Q2
$751K Sell
37,988
-334,692
-90% -$5.7M ﹤0.01% 1527
2016
Q1
$6.33M Buy
372,680
+341,664
+1,102% +$5.71M 0.02% 528
2015
Q4
$635K Hold
31,016
﹤0.01% 870
2015
Q3
$668K Sell
31,016
-138,176
-82% -$3.08M ﹤0.01% 846
2015
Q2
$3.38M Hold
169,192
0.01% 716
2015
Q1
$2.63M Buy
169,192
+9,200
+6% +$139K 0.01% 750
2014
Q4
$2.2M Buy
159,992
+4,800
+3% +$58.8K 0.01% 764
2014
Q3
$1.55M Buy
155,192
+8,292
+6% +$84.8K 0.01% 824
2014
Q2
$1.45M Buy
146,900
+23,600
+19% +$209K ﹤0.01% 818
2014
Q1
$1.27M Hold
123,300
﹤0.01% 831
2013
Q4
$1.09M Sell
123,300
-19,600
-14% -$155K ﹤0.01% 843
2013
Q3
$1.01M Sell
142,900
-204,700
-59% -$1.3M ﹤0.01% 799
2013
Q2
$1.95M Buy
+347,600
New +$1.66M 0.01% 406

Other funds holding DXCM

Canada Life's DXCM Position: Q1 2026 in Review

Canada Life reduced its DexCom (DXCM) stake by 0.71% in Q1 2026, selling an estimated $147K and leaving 294,065 shares worth $18.5M. The position accounts for 0.03% of the portfolio, ranked #383.

Canada Life first reported a position in DXCM in Q2 2013 and has held it in 52 quarters since. The position peaked at $41.4M in Q1 2024. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Canada Life held 294,065 shares of DexCom worth $18.5M as of Q1 2026.
  • Canada Life sold 2,116 DexCom shares in Q1 2026, an estimated $147K.
  • DexCom made up 0.03% of Canada Life's portfolio in Q1 2026, its #383 holding.
  • Canada Life first reported a position in DexCom in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's DexCom position peaked at $41.4M in Q1 2024.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.